Afya Limited (AFYA)
$
13.76
+0.26 (1.89%)
Key metrics
Financial statements
Free cash flow per share
12.7892
Market cap
6.6 Billion
Price to sales ratio
1.7870
Debt to equity
0.2322
Current ratio
2.1969
Income quality
1.7576
Average inventory
0
ROE
0.1624
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Afya Limited, through its subsidiaries, operates as a prominent medical education group in Brazil, offering a diverse array of educational products and services. These include medical schools, medical residency preparatory courses, graduate courses, and various programs aimed at lifelong medical learners within its distribution network as well as to third-party medical schools. The operating expenses amount to $1,147,169,409.00 encompassing various operational costs incurred. Additionally, Afya provides digital health services through a subscription-based mobile app and website portal, which are designed to aid health professionals and students with clinical decision-making by offering tools such as medical calculators, charts, and updated content on prescriptions, clinical scores, medical procedures, and laboratory exams. The earnings per share (EPS) is reported at $8.16 indicating the company's profitability on a per-share basis. As part of its educational offerings, Afya provides health sciences courses including medicine, dentistry, nursing, and other disciplines as well as degree programs in subjects like business administration and civil engineering. The operating income ratio is 0.33 reflecting the company's operational profitability margin. As of December 31, 2021, the company operated a network of 46 undergraduate and graduate medical school campuses, consisting of 30 undergrad operating units and five approved units, with a total of 2,731 medical school seats, which included 2,481 operating seats and 278 approved seats. Founded in 1999 and headquartered in Nova Lima, Brazil, the weighted average number of diluted shares outstanding is 91,267,611.00 reflecting potential dilution effects and highlighting the company's shareholder base. The affordability of Afya’s stock at $15.82 makes it suitable for budget-conscious investors. With a market capitalization of $1,244,446,749.00 the company is classified as a small-cap player within the medical education sector. Additionally, the stock has a low average trading volume of 112,445.00 indicating lower market activity which could reflect on its liquidity. It is a key player in the Education & Training Services industry, contributing significantly to the overall market landscape, and it belongs to the Consumer Defensive sector, driving innovation and growth. The dynamic presence of Afya Limited not only enhances the educational landscape but also underscores its commitment to advancing health education in Brazil, thereby reinforcing its strategic position in the market.
Is Afya Limited (AFYA) a good investment?
Investing in Afya Limited (AFYA) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A, with a Bullish outlook. Always conduct your own research before investing.
What is Afya Limited (AFYA)'s stock forecast?
Analysts predict Afya Limited stock to fluctuate between $13 (low) and $19.90 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Afya Limited's market capitalization?
As of 2026-03-16, Afya Limited's market cap is $1,244,446,749, based on 90,439,444 outstanding shares.
How does Afya Limited compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Afya Limited has a Lower Market-Cap, indicating a difference in performance.
Does Afya Limited pay dividends?
Afya Limited pays dividends. The current dividend yield is 1.29%, with a payout of $0.23 per share.
How can I buy Afya Limited (AFYA) stock?
To buy Afya Limited (AFYA) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AFYA. Place an order (Market, Limit, etc.).
What is the best time to invest in Afya Limited?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Afya Limited perform in the last earnings report?
Revenue: $3,624,629,082 | EPS: $8.16 | Growth: 16.41%.
Where can I find Afya Limited's investor relations reports?
Visit https://www.afya.com.br/investor-relations for detailed financial reports.
Where can I find historical stock prices for Afya Limited?
You can explore historical data from here
What is the all-time high and low for Afya Limited stock?
All-time high: $25.07 (2021-08-05) | All-time low: $8.73 (2022-07-12).
What are the key trends affecting Afya Limited stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Investors interested in stocks from the Schools sector have probably already heard of Afya (AFYA) and Grand Canyon Education (LOPE). But which of these two stocks offers value investors a better bang for their buck right now?
seekingalpha.com
Afya Limited (AFYA) Q4 2025 Earnings Call Transcript
zacks.com
Afya (AFYA) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.36 per share a year ago.
businesswire.com
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the fourth quarter and full-year period ended December 31, 2025. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Fourth Quarter 2025 Highlights 4Q25 Revenue.
businesswire.com
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced that its board of directors (the “Board”) approved its second distribution of a cash dividend. On March 12, 2026, the Company's Board of Directors approved dividend distribution in the amount of R$307.4 million, representing 40% of the Company's consolidated net income for the year ended Decem.
businesswire.com
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and provider of medical practice solutions in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) has authorized an increase of 63 medical seats for ITPAC – Instituto Tocantinense Presidente Antonio Carlos Porto S.A. (“Afya Abaetetuba”), located in the city of Abaetetuba, in t.
businesswire.com
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that Mrs. Maria Tereza Azevedo notified the Company of her intent to resign as a member of the Board of Directors of the Company, effective as of December 31, 2025. Afya thanks Maria Tereza for her dedication and meaningful contributions to the Board and wishes her continued success in h.
seekingalpha.com
Afya Limited ( AFYA ) Q3 2025 Earnings Call November 12, 2025 5:00 PM EST Company Participants Renata Couto - Investor Relations Executive Manager Virgilio Deloy Gibbon - Chief Executive Officer Luis Andre Blanco - Chief Financial Officer Conference Call Participants Lucca Marquezini - Itaú Corretora de Valores S.A., Research Division Lucas Nagano - Morgan Stanley, Research Division Marcelo Santos - JPMorgan Chase & Co, Research Division Mirela Rodrigues de Oliveira - BofA Securities, Research Division Renan Prata - Citigroup Inc. Exchange Research Presentation Renata Couto Investor Relations Executive Manager Thank you for joining us for Afya's conference call.
zacks.com
Afya (AFYA) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.32 per share a year ago.
businesswire.com
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and nine-month period, which ended September 30, 2025 (third quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2025 High.
See all news
